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Abstract
Purpose: Most children with spina bifida now survive into adulthood, although most have 
neuropathic bladder with potential complications of incontinence, infection, renal damage and 
diminished quality of life. In this study we sought to 1) describe contemporary bladder 
management and continence outcomes of adults with spina bifida, 2) describe differences from 
younger individuals and 3) assess for association with socioeconomic factors.
Materials and Methods: We analyzed data on bladder management and outcomes in adults 
with spina bifida from the National Spina Bifida Patient Registry. A strict definition of continence 
was used. Results were compared to young children (age 5 to 11 years) and adolescents (12 to 19). 
Statistical analysis compared cohorts by gender, ethnicity, spina bifida type, lesion level, insurance 
status, educational attainment, employment status and continence.
Results: A total of 5,250 patients with spina bifida were included, of whom 1,372 (26.1%) were 
adults. Of the adult patients 45.8% did not take medication, but 76.8% performed clean 
intermittent catheterization. Continence was decreased in adults with myelomeningocele (45.8%) 
vs those with non-myelomeningocele spina bifida (63.1%, p <0.0001). Continence rates were 
higher in the older cohorts with myelomeningocele (p <0.0001) but not in those with non-
myelomeningocele spina bifida (p 1/4 0.1192). Bladder management and history of urological 
surgery varied among age groups. On univariate analysis with spina bifida related or 
socioeconomic variables continence was significantly associated with educational level but on 
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multivariable logistic regression analysis bladder continence was significantly associated with 
employment status only.
Conclusions: Bladder management techniques differ between adults and children with spina 
bifida. Bladder continence outcomes were better in adults, with nearly half reporting continence. 
Continence was significantly associated with employment status in patients age 25 years or older.
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DUE to medical advancements, nearly all children born with spina bifida survive into 
adulthood so that today most Americans living with spina bifida are adults.1 Neuropathic 
bladder impairment is present in most of these patients, with potential sequelae of 
incontinence, recurrent urinary tract infections, chronic renal insufficiency and diminished 
quality of life.2–4 With the increased number of older patients the transition to adult care has 
become an important component of urological spina bifida care.5
The National Spina Bifida Patient Registry, funded through the Centers for Disease Control 
and Prevention, began collecting data from multidisciplinary spina bifida clinics across the 
US in 2009. The primary goals were to describe patients attending those clinics, provide a 
foundation for research and improve clinical care.6 Secondarily the registry has enabled 
collaborative research across multiple time points. The registry includes more than 6,000 
cases with sufficient granularity to study bladder management and continence outcomes.7
Currently few data are available regarding urological care in adults with SB. We sought to 1) 
describe contemporary bladder management and continence outcomes in adults with SB, 2) 
describe differences between adults and younger individuals, and 3) assess for association 
with socioeconomic factors to improve care and develop realistic expectations for 
individuals with SB of all ages and their families. We hypothesized that adults would differ 
from younger patients, and that continence would be associated with better educational and 
employment outcomes.
METHODS
The NSBPR uses a standardized tool to collect longitudinal data from patients with spina 
bifida at 26 sites with 6 diagnoses, including MMC, meningocele, lip-omyelomeningocele, 
split cord malformation, terminal myelocystocele and fatty filum.8 After local institutional 
review board approval parents and patients gave informed consent. Enrollment of all eligible 
patients was encouraged but not required. Baseline demographic and diagnostic information 
was collected at enrollment, and updated demographic and clinical data were gathered 
yearly. The data used were obtained at the most recent clinic visit through medical record 
abstraction and patient interview.
Sociodemographic Characteristics
Patients were segregated according to age as school-age (5 to 11 years), adolescent (12 to 
19) and adult (20 or older) to compare treatment techniques and outcomes. Race/ethnicity 
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was classified as nonHispanic white, nonHispanic black, Hispanic or Latino and other. 
Health insurance was categorized as private or nonprivate. College attendance, graduation 
rates and current employment status (full-time or part-time vs other, ie not employed, 
retired, volunteer or occasional worker) were studied in patients age 25 years or older.9
SB Lesion Characteristics and Motor Function
SB diagnosis was classified as MMC or nonMMC. Functional lesion level was reported for 
each lower extremity and defined by the more severe side.
Continence Outcomes
During initial data collection (through September 2013) urinary continence was defined as 
“dry, with or without interventions, during the day.” Later (October 2013 to December 2015) 
continence was evaluated by multiple choices to “Quantify frequency of bladder 
incontinence during the day over the last month (when not having a UTI).” Only answers of 
“Never” or “Less than once per month” were considered as continent. Individuals using one 
of several forms of bladder management were considered incontinent regardless of their 
response, including urostomy bag, vesicostomy, indwelling catheter and condom catheter. 
Responses of “Cannot assess” (90 patients) were excluded.
Management Techniques
Daily antibiotic and antimuscarinic medication usage was analyzed. Surgical history was 
obtained for bladder augmentation, continent catheterizable urinary channel (Mitrofanoff 
appendicovesicostomy and Monti reconfigurated small bowel), cutaneous vesicostomy, 
bladder outlet operation for continence and urinary stone removal. Bladder management 
techniques were queried and categorized as no management (incontinent in diaper), 
spontaneous voiding, CIC, indwelling catheter, cutaneous vesicostomy, urostomy (into 
external appliance), Credé maneuver and condom catheter.
Statistical Analysis
Associations among independent categorical variables were tested using chi-square analysis. 
Multivariable logistic regression models were used to test the association of bladder 
continence outcomes with gender, SB type, level of lesion, health insurance type, 
employment status and educational attainment. Statistical tests were all 2-sided, and p <0.05 
was considered significant. Statistical analyses were performed using SAS®, version 9.3.
RESULTS
Demographics
The analysis included 5,250 participants 5 to 83 years old at their last clinic visit through 
December 2015 (table 1). Adults comprised only 26.1% of the registry participants as clinics 
at pediatric hospitals represented the majority of enrolled sites. The proportion of females 
was slightly higher in the 2 younger cohorts and significantly higher in the adult cohort. 
Racial and ethnic distribution varied with age, with higher proportions of nonHispanic 
whites in the older groups and a higher proportion of Hispanic/Latinos in the youngest. 
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There was a larger proportion of adults with MMC and with higher level lesions. The 
proportion of participants with any private insurance was lower in adults. Patient reported 
employment status was low, with the majority of adolescents and nearly 1 of 5 adults 
identifying as students. Slightly more than 1 of 4 adults reported being permanently 
disabled.
Bladder Management
The proportion of patients using daily antibiotics was low but was increased in adults (table 
2). Approximately half of patients used antimuscarinic medication, with decreasing use in 
older cohorts. Alpha-adrenergic receptor agonist and antagonist medication usage to 
improve continence or voiding was uncommon and was reported by 6 and 2 patients, 
respectively.
Analysis of urological surgical history showed an increased prevalence of bladder 
augmentation, with almost 1 of 4 adults reporting having undergone augmentation. Creation 
of a continent catheterizable channel (Mitrofanoff or Monti) was greater in adolescents 
(13.1%) compared to adults (8.1%) and school-age children (7.5%). Proportions of patients 
with a history of cutaneous vesicostomy or bladder outlet operation were higher in 
adolescents compared to other age groups. By contrast, history of surgery for stones was 
more prevalent in adults.
For bladder management choices of “no management” and “spontaneous voiding in toilet” 
decreased in older age groups. CIC usage was similar in adolescents and adults and was 
greater than in school-age children. Management by cutaneous vesicostomy decreased with 
age. Management by indwelling catheter, urostomy bag (incontinent diversion), Credé 
maneuver or condom catheter was relatively rare but was more common in adults.
Segregation of patients by SB type also demonstrated differences in use of CIC by age (table 
3). Overall, 4 of 5 patients with MMC used CIC, with adolescents comprising the highest 
proportion (83.8%), while only 2 of 5 patients with nonMMC SB performed CIC, with 
adults comprising the highest proportion (59.5%). Comparison of adults revealed a 
significant difference only in CIC usage between patients with (79.5%) and without MMC 
(59.5%, p <0.0001).
Bladder Continence Outcomes
Of the entire cohort 2,284 (43.5%) were considered continent. Interestingly 118 of 293 
participants (40.3%) with incontinent forms of bladder management reported continence 
when asked but were considered incontinent by definition for this analysis. Bladder 
continence increased with age (36.9% in school-age children, 47.1% in adolescents and 
48.2% in adults, p <0.0001). Segregation by SB type (table 3) showed that continence also 
increased significantly among age groups with MMC, although no statistically significant 
difference was seen between age groups with nonMMC diagnosis. Of adults continence was 
lower in those with MMC (45.8%) vs nonMMC SB (63.1%, p <0.0001).
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Segregation by Education Level in Adults Age 25 Years or Older
Almost half of patients age 25 years or older pursued post-high school education, with only 
1 of 5 attaining a college degree or higher (table 4). Educational attainment did not vary 
significantly with gender. Employment and private health insurance were associated with 
higher education, as were nonMMC SB and lower lesion levels. Among the 3 education 
groups only those with a college degree exceeded 50% continence rate, and continence was 
significantly associated with education level (p = 0.0077).
Multiple Logistic Regression Models in Adults Age 25 Years or Older
Multiple logistic regression models with SB related and socioeconomic variables 
demonstrated significant associations between bladder continence and employment status. 
After controlling for all other variables full-time and part-time workers were more continent 
than others (p = 0.0232, table 5). Educational attainment was not associated with continence 
when controlling for other variables.
DISCUSSION
This analysis of bladder management and continence outcomes in SB represents the largest 
cohort of adults described to date. These data are helpful not only to evaluate current care, 
but also to provide realistic expectations to younger individuals about future management 
and outcomes. Furthermore, we noted significant differences among adults compared to 
younger patients.
Variation in neuropathic bladder dysfunction was expected as the neuropathy associated with 
SB is a spectrum. Our adult cohort had a greater prevalence of the MMC form of SB and 
higher lesion level than younger cohorts. This difference could be explained by a tendency 
of adults with milder forms of SB to be less likely to receive care at multidisciplinary SB 
clinics.
Overall usage of CIC among adults was 76.8% (79.5% for MMC and 59.5% nonMMC) and 
bladder continence was 48.2% (45.8% and 63.1% for MMC and nonMMC, respectively). 
Liu et al noted a similar rate of CIC usage, at 71% in 225 adults with SB, of whom 87% had 
MMC.10 Another study of 65 individuals with SB at 2 adult clinics revealed nearly identical 
rates of continence (48%) and CIC (77%).5 An international online survey of 518 adults 
with SB showed similar CIC usage (76%), although bladder continence was notably lower at 
23.7%.11 It is unclear if the lower continence was due to the voluntary and private nature of 
the online survey or a different definition of continence. Nonetheless, these studies 
demonstrate that most adults with SB utilize CIC, even with nonMMC defects, and that 
bladder continence is attainable for a large proportion.
Our adult cohort had a higher proportion of females compared to younger cohorts. This 
group was less skewed than the adult SB group reported by Liu et al, which was two-thirds 
female.10 Perhaps females are more likely than males to seek treatment at NSBPR clinics, or 
males with SB have decreased longevity compared to females. Nonetheless, no continence 
differences were associated with gender. We also noted that the racial and ethnic mix of the 
population with spina bifida in the US has been changing through time, as seen in the 26 
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NSBPR sites in 20 states. The younger 2 cohorts had proportionally fewer nonHispanic 
white patients and more Hispanics/Latino patients. This finding likely reflects increased 
immigration of Hispanic/Latino individuals to the US in recent decades, and this population 
has a higher incidence of SB and higher birth rates.12
Usage of daily antibiotics was greater in adults. It is not known if this strategy to prevent 
UTI was begun in these patients when such practice was more common or if they indeed 
have more UTIs. However, use of antimuscarinic medication was decreased in adults despite 
improved continence rates and was similar to usage reported by Liu et al (49%).10 This 
finding could be related to a higher proportion of patients with a history of bladder 
augmentation, which typically obviates the need for such medication. The higher proportion 
of adults who had undergone bladder augmentation may be a reflection of increasing 
surgical indications with age due to bladder hostility, increasing desire for continence or 
prior practice patterns that more aggressively relied on augmentation.
The proportions of patients undergoing specific surgeries also could have been affected by 
prior surgical choices. For instance patients with a vesicostomy do not undergo bladder 
augmentation and vice versa. Adults underwent fewer surgeries to create continent 
catheterizable channels compared to adolescents, likely due to the fact that these operations 
have come into favor only in the last 2 decades. Summers et al noted a similar rate for prior 
bladder augmentation in their adult clinics (29%).5 Patients with SB have a greater risk of 
urolithiasis compared to the general population that increases with age,13 so an increased 
incidence of stone surgery in adults was not unexpected. The higher proportion of 
adolescents undergoing bladder outlet surgery for continence may be a reflection of an 
evolution of more aggressive efforts to help patients with spina bifida attain continence.
The proportion of individuals with no bladder management decreased with age. This finding 
may explain why bladder continence improved with age, from 36.9% in school-age children 
to 48.2% in adults. Bladder continence was significantly greater in adults with nonMMC 
compared to MMC SB. Adults were more likely to perform CIC and less likely to void 
spontaneously but CIC was less frequently used by adults with nonMMC SB. However, 
nearly 7% of all adults had an indwelling catheter or urostomy bag. It is unclear if this 
finding reflects older practice patterns or aging related sequelae such as progression of 
incontinence, declining mobility, inability to manage the bladder independently and 
increasing incidence of pressure ulcers.14 Regardless, as more individuals with SB survive 
further into adulthood, it will be important to determine if forms of bladder management 
change due to SB related factors or changes in practice paradigms. Inclusion of urodynamic 
parameters (added to phase 2 of the NSBPR) in future studies should further our 
understanding of the bladder pathology underlying these findings.
Our socioeconomic findings have implications for the social, educational and vocational 
development of individuals with SB. We previously analyzed socioeconomic factors in the 
same adult cohort of patients in the NSBPR and found bowel continence to be associated 
with higher employment rates and educational attainment on univariate analysis and with 
employment only on multivariable logistic regression analysis.15 In the current analysis of 
urinary parameters similar statistically significant associations were found between bladder 
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continence and educational attainment/employment status. These associations were not 
appreciated on the initial analysis before excluding those with incontinent forms of 
management.15
These findings add to the growing body of literature investigating the impact of continence 
on QOL. Szymanski et al noted that QOL of adult patients with spina bifida was more 
negatively affected by any bowel incontinence than by low volume bladder incontinence.11 
Similarly Liu et al found that QOL outcomes in 66 adults with SB did not differ based on 
bladder management techniques.3
Our study has several potential limitations. As with any large database, errors in patient 
recall and data entry could have occurred. The NSBPR carefully standardizes data 
components and collection and has ongoing data quality monitoring.7 There is potential for 
selection bias at NSBPR clinics but analyses have revealed no significant differences in 
eligible, but not enrolled, patients in these clinics.16 Adults in the registry may not be 
representative of all adults with SB because they may be receiving more intensive and 
systematic care in selected clinics than patients receiving care elsewhere. Furthermore, 
adults attending these clinics may have a higher level of SB related disease burden than 
those not attending selected clinics. The age distribution of adults in the NSBPR is skewed 
toward young adults, so these findings may not be representative of older adults with SB. 
Finally, refinement of the definition of continence during the study period could have 
impacted the continence outcomes findings.
CONCLUSIONS
This analysis, which is the largest to date of bladder management and continence outcomes 
in adults with SB, found significant differences compared to adolescents and younger 
children. Management and outcomes varied by SB type but overall more than three-fourths 
of adults performed CIC. Bladder continence improved with age for patients with MMC and 
was significantly associated with employment status. These findings may help guide 
management of neuropathic bladder in adults with SB and provide realistic goals for 
younger individuals.
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Table 5.
Odds association of bladder continence with key characteristics of patients older than 25 years with SB, based 
on multivariable logistic regression
OR (95% CI) p Value
Gender:  0.34
 Male Referent
 Female 1.16 (0.86, 1.57)
Employment:  0.0232
 Full-time/part-time Referent
 Other 0.69 (0.49, 0.95)
Health insurance:  0.29
 Any private Referent
 Nonprivate 0.84 (0.60, 1.17)
Spina bifida type:  0.90
 Myelomeningocele Referent
 Other diagnosis 1.03 (0.62, 1.71)
Level of lesion:  0.1057
 Thoracic Referent
 High lumbar 0.99 (0.59, 1.65)
 Mid lumbar 1.09 (0.74, 1.16)
 Low lumbar 1.00 (0.58, 1.71)
 Sacral 1.83 (1.83, 2.95)
Education:  0.23
 High school or less Referent
 Technical school or some college 1.31 (0.91, 1.87)
 College or higher 1.33 (0.87, 2.02)
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